Bill:  HB 2529 
Legislative Session: 88(R) Council Document: 88R 458 KKR-D
Add to Bill List
Last Action:05/01/2023 H Left pending in committee
Caption Version:Introduced
Caption Text:Relating to written notification provided by drug manufacturers regarding the cause of generic insulin prescription drug unavailability.
Author:Talarico
Subjects:Health--Other Diseases & Medical Conditions (I0383)
Insurance--Health & Accident (I0422)
DIABETES (S0486)
MEDICINE & PRESCRIPTION DRUGS (S7338)
HEALTH & HUMAN SERVICES COMMISSION (V0177)
Companion:SB 241 by Perry, Identical
House Committee:Public Health
Status:In committee
Actions: (descending date order)
Description Comment Date       Time       Journal Page
H   Left pending in committee      05/01/2023    
H   Testimony taken/registration(s) recorded in committee      05/01/2023    
H   Considered in public hearing      05/01/2023    
H   Scheduled for public hearing on . . .      05/01/2023    
H   Referred to Public Health      03/13/2023   03:37 PM  601
H   Read first time      03/13/2023     601
H   Filed      02/21/2023